Showing results (1801-1810 of 2,348) with videos related to
Sort By:
Pageof 235
The AAPS Journal|March 29, 2018
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.The AAPS Journal|December 29, 2017
Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic ModelingQianwen Wang, Yufeng Zhang, Chun-Ho Wong, et al.The AAPS Journal|December 22, 2017
In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer PreventionChristina N Ramirez, Wenji Li, Chengyue Zhang, et al.The AAPS Journal|December 2, 2017
Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular LevelVerena Schneider, Selim Chaib, Claudia Spanier, et al.The AAPS Journal|October 4, 2017
How Close Are We to Profiling Immunogenicity Risk Using In Silico Algorithms and In Vitro Methods?: an Industry PerspectiveJochem Gokemeijer, Vibha Jawa, Shibani Mitra-KaushikThe AAPS Journal|October 4, 2017
Recommendations for Selection and Characterization of Protein Biomarker Assay Calibrator MaterialKyra J Cowan, Lakshmi Amaravadi, Mark J Cameron, et al.The AAPS Journal|July 2, 2016
Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological DataDaniel Scotcher, Christopher Jones, Maria Posada, et al.The AAPS Journal|December 20, 2018
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic InformationIris Detrez, Ganel Schops, Jolien Lefrère, et al.The AAPS Journal|July 1, 2006
Mechanisms of methamphetamine-induced dopaminergic neurotoxicityEvan L Riddle, Annette E Fleckenstein, Glen R HansonThe AAPS Journal|July 1, 2006
Developmental toxicity of prenatal exposure to tolueneScott E Bowen, John H HanniganPageof 235